Rhythm Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RYTM for the last quarter is 33.25 M USD, and it's 14.35% higher compared to the previous quarter. The net income of Q3 24 is -43.64 M USD.